Propel Bio Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Propel Bio Management's COLL Position: Q3 2026 in Review
Propel Bio Management opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 410,175 shares worth $8.95M. The stake represents 4.75% of the portfolio and ranks #4 among its holdings.
240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- Propel Bio Management held 410,175 shares of Collegium Pharmaceutical worth $8.95M as of Q3 2026.
- Collegium Pharmaceutical was a new Propel Bio Management position in Q3 2026.
- Collegium Pharmaceutical made up 4.75% of Propel Bio Management's portfolio in Q3 2026, its #4 holding.
- 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on Propel Bio Management's 13F filing for Q3 2026, filed 13 Nov 2026.